并基于此建立了中国医药产业研发生产力的表征指标体系和影响因素体系。
Second, the econometric model of the Chinese pharmaceutical R&D productivity of the Chinese pharmaceutical industry is constructed based on the data collected.
不幸的是，这种损失恰逢研发生产力的衰退：实验室里研发出药物无法取代那些失去专利保护的药物。
Unfortunately, these losses have coincided with a decline in R&D productivity: the drugs discovered in the labs are not replacing the value of those medicines losing patent protection.
应用推荐